Allergy

Resource Center

FDA Alerts

allergy

FDA Approves New Option for Chronic Rhinosinusitis With Nasal Polyps

06/26/2019

The FDA has approved the first treatment option for chronic, inadequately controlled rhinosinusitis with nasal polyps.

06/26/2019

Research Summaries

treatment

Exacerbations Increased After Discontinuing Long-term Use of Mepolizumab for Severe Eosinophilic Asthma

08/19/2022

While the long-term safety and efficacy of mepolizumab have been studied, gaps in the literature have remained on the clinical impact of stopping mepolizumab after long-term use. Researchers examined how...

08/19/2022

allergy

FDA Approves New Option for Chronic Rhinosinusitis With Nasal Polyps

06/26/2019

The FDA has approved the first treatment option for chronic, inadequately controlled rhinosinusitis with nasal polyps.

06/26/2019

allergy

Epinephrine Is Underused During Serious Reactions

06/21/2018

Previous research has suggested that emergency use and daily carriage of epinephrine auto-injectors is inadequate.

06/21/2018

allergy

Management of Anaphylaxis in Infants and Toddlers: What Are We Missing in Practice?

03/20/2018

An estimated 5.9 million children in the United States have food allergies, and food allergy is the leading cause of anaphylaxis in young children.

03/20/2018

allergy

Penicillin Allergy Is Often Overreported

10/31/2017

In a recent study, researchers sought to test the real-world feasibility of a simple test to identify patients who have been mislabeled as allergic to penicillin.

10/31/2017

April 2024

Current Issue

April 2024

Volume 64

Issue 4